DCF — MILLS PENINSULA MEDICAL CENTER
Enterprise Value: $132.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$132.4M
Enterprise Value
$20.8M
PV of Cash Flows
$111.6M
PV of Terminal Value
$179.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $725.9M | $30.5M | 4.0% | $-3.3M | $-3.0M |
| Year 2 | $747.7M | $38.9M | 5.0% | $2.2M | $1.8M |
| Year 3 | $770.1M | $47.8M | 6.0% | $8.1M | $6.1M |
| Year 4 | $793.2M | $53.2M | 7.0% | $11.3M | $7.7M |
| Year 5 | $817.0M | $56.8M | 7.0% | $13.2M | $8.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $132.4M. Terminal value accounts for 84% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$704.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03707063240202989
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5